Atea Pharmaceuticals Inc. (AVIR): Price and Financial Metrics
AVIR Price/Volume Stats
Current price | $3.13 | 52-week high | $4.60 |
Prev. close | $3.12 | 52-week low | $2.75 |
Day low | $3.09 | Volume | 36,698 |
Day high | $3.16 | Avg. volume | 424,968 |
50-day MA | $3.20 | Dividend yield | N/A |
200-day MA | $3.50 | Market Cap | 264.37M |
AVIR Stock Price Chart Interactive Chart >
Atea Pharmaceuticals Inc. (AVIR) Company Bio
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
AVIR Price Returns
1-mo | -6.85% |
3-mo | -10.57% |
6-mo | -7.12% |
1-year | -24.58% |
3-year | -54.44% |
5-year | N/A |
YTD | -6.57% |
2024 | 9.84% |
2023 | -36.59% |
2022 | -46.20% |
2021 | -78.60% |
2020 | N/A |
Loading social stream, please wait...